Day Trade Cheat Sheet - March 04, 2026 (EOD)

 ## TODAY'S GRADE: A Strong broad-market rally led by tech and small caps amid easing Iran conflict fears and solid jobs data made for a highly favorable day for day traders. ## HOW INDEXES TRADED **SPY:** +0.86% - trending higher with steady gains **QQQ:** +1.67% - strong leadership from tech, clear uptrend **IWM:** +0.99% - solid small-cap strength, consistent upward momentum ## BIGGEST MOVERS ### Winners **$ALTO** +33.85% - strong Q4 earnings and upbeat outlook **$ACEL** +17.98% - positive earnings surprise and analyst upgrades **$STVN** +18.81% - robust Q4 results and margin expansion **$NAGE** +21.97% - strong earnings and growth outlook **$COIN** +13.79% - surge on Trump’s support for crypto market bill **$ASTS** +12.56% - new satellite contract and growth guidance **$VEEV** +11.89% - agentic transformation driving strong Q4 results **$BOX** +10.16% - margin improvement and revenue growth **$PLUG** +9.43% - revenue beat and first positive gross margin **$EYE** +9.05% - analyst upgrades and buy rating maintained ### Losers **$ACNT** -19.04% - disappointing earnings and guidance cut **$CPIX** -19.21% - weak revenue and profit miss **$SSTI** -18.90% - continued losses and negative sentiment **$HRZN** -22.59% - earnings miss and margin pressure **$SES** -16.14% - weak Q4 results and guidance **$INDI** -16.78% - earnings update and analyst downgrades **$RIGL** -10.66% - revenue miss and cautious outlook **$FTEK** -10.14% - earnings disappointment and margin concerns **$WBTN** -9.46% - earnings miss and negative sentiment **$GENI** -6.65% - revenue miss and guidance cut ## WHAT WORKED Patterns or setups that worked today: - Earnings gap-ups with strong volume in growth and AI-related tech stocks like **$NVDA**, **$VEEV**, **$PLUG**, and **$COIN**. These showed sustained follow-through after earnings beats and positive guidance. - Small-cap breakouts in rare earths and biotech, such as **$ALTO**, **$NAGE**, and **$STVN**, which benefited from strong earnings and sector tailwinds. - Defensive rotation into gold and energy-related names amid geopolitical tensions, with **$GLD** up 1.29% and oil ETF **$USO** +2.00%. ## WHAT FAILED Setups that didn't work: - Some beaten-down speculative biotech and tech names with weak earnings or guidance, such as **$ACNT**, **$CPIX**, and **$HRZN**, failed to hold support and sold off sharply despite oversold conditions. - Retail and consumer discretionary shorts on names like **$ANF** (-3.60%) and **$RCL** (-4.68%) were challenged as broader market strength lifted many beaten-down cyclicals. - Energy names like **$XLE** (-0.60%) and **$XOM** (-1.42%) lagged despite oil price strength, reflecting profit-taking and mixed sector sentiment. ## AFTER-HOURS WATCH Earnings or news to monitor tonight: - **$AVGO** (Broadcom) - AI revenue beat and strong guidance expected after the bell, likely to influence tech sector sentiment tomorrow. - **$COST** (Costco) - Q2 earnings preview with potential commentary on tariffs and retail strength, key for consumer discretionary outlook. - **$OKTA** - Q4 earnings slides show revenue beat and AI focus, watch for guidance impact. - **$VSTM** (Verastem) - Q4 earnings call transcript available, may influence biotech sentiment. - **$PAGS** (PagSeguro) - Q4 earnings call transcript, watch for fintech growth signals. ## TOMORROW PREVIEW **Early Watch:** - **$AVGO**, **$COST**, **$OKTA**, **$VSTM**, **$PAGS** for earnings-driven moves - Continued momentum names like **$NVDA**, **$MU**, **$AMZN**, and **$TSLA** for follow-through - Watch beaten-down biotech names for potential bounces or further weakness **Catalyst:** - Earnings from Broadcom, Costco, Okta, and fintech/biotech names - Economic data expected to remain supportive with recent strong jobs reports and easing inflation fears - Geopolitical developments in Middle East and oil market supply dynamics **Bias:** - Bullish into tomorrow, supported by strong tech leadership, positive earnings momentum, and easing geopolitical risk. However, caution warranted on speculative biotech and energy sectors amid mixed signals.